We are live on ! Find out more
CIP

Champlain Investment Partners Portfolio holdings

AUM $3.89B
1-Year Est. Return 16.15%
This Fund
S&P 500
This Quarter Est. Return
+4.71%
1 Year Est. Return
+16.15%
3 Year Est. Return
+48.47%
5 Year Est. Return
+55.5%
10 Year Est. Return
+378.36%
AUM
$9.25B
AUM Growth
+$413M
Cap. Flow
+$139M
Cap. Flow %
1.51%
Top 10 Hldgs %
19.61%
Holding
128
New
12
Increased
58
Reduced
52
Closed
5

Sector Composition

Rank Sector Weight
1 Healthcare 24.16%
2 Technology 18.9%
3 Industrials 15.71%
4 Financials 15.64%
5 Consumer Staples 12.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DATA
51
DELISTED
Tableau Software, Inc.
DATA
$79.2M 0.86%
979,720
-87,770
-8% -$6.95M
BUFF
52
DELISTED
Blue Buffalo Pet Products, Inc
BUFF
$79M 0.85%
1,983,785
-10,125
-0.5% -$365K
EW icon
53
Edwards Lifesciences
EW
$49.4B
$78.7M 0.85%
1,692,075
+191,055
+13% +$8.3M
ANSS
54
DELISTED
Ansys
ANSS
$78.1M 0.84%
498,390
-63,050
-11% -$10.1M
SRCL
55
DELISTED
Stericycle Inc
SRCL
$76.5M 0.83%
1,307,693
+244,095
+23% +$16.5M
WWW icon
56
Wolverine World Wide
WWW
$1.56B
$75M 0.81%
2,593,570
-1,018,140
-28% -$31.4M
GTES icon
57
Gates Industrial Corp
GTES
$6.47B
$74.9M 0.81%
+4,278,620
New +$77.1M
HELE icon
58
Helen of Troy
HELE
$628M
$74.5M 0.81%
856,225
+187,780
+28% +$17.1M
STE icon
59
Steris
STE
$20.6B
$73.6M 0.8%
788,560
-139,975
-15% -$12.7M
CBSH icon
60
Commerce Bancshares
CBSH
$8.39B
$71.4M 0.77%
1,761,647
-912
-0.1% -$36.2K
SXT icon
61
Sensient Technologies
SXT
$5.4B
$65.9M 0.71%
933,930
+653,380
+233% +$47M
OMCL icon
62
Omnicell
OMCL
$1.49B
$65.3M 0.71%
1,505,445
+46,390
+3% +$2.13M
SXI icon
63
Standex International
SXI
$3.14B
$64.3M 0.69%
674,220
-21,580
-3% -$2.16M
LDL
64
DELISTED
Lydall, Inc.
LDL
$63.7M 0.69%
1,320,360
-42,955
-3% -$2.06M
SBH icon
65
Sally Beauty Holdings
SBH
$1.48B
$63.5M 0.69%
3,860,690
+135,555
+4% +$2.32M
HSIC icon
66
Henry Schein
HSIC
$9.75B
$61.7M 0.67%
1,169,666
-1,237
-0.1% -$68.5K
MASI
67
DELISTED
Masimo
MASI
$60.9M 0.66%
692,780
+494,180
+249% +$43.1M
PBH icon
68
Prestige Consumer Healthcare
PBH
$2.2B
$59.8M 0.65%
1,774,055
+647,440
+57% +$24.8M
P
69
Everpure Inc
P
$32.3B
$59.7M 0.65%
2,990,675
+1,431,580
+92% +$28.1M
BGS icon
70
B&G Foods
BGS
$256M
$59.6M 0.64%
2,514,685
+128,055
+5% +$3.92M
SUPN icon
71
Supernus Pharmaceuticals
SUPN
$2.37B
$58.4M 0.63%
1,275,155
+62,370
+5% +$2.6M
ICUI icon
72
ICU Medical
ICUI
$3.89B
$57.6M 0.62%
228,325
-108,820
-32% -$25.6M
SNPS icon
73
Synopsys
SNPS
$70.7B
$57.1M 0.62%
686,287
+25,685
+4% +$2.26M
WEX icon
74
WEX
WEX
$6.89B
$57M 0.62%
363,805
-844,020
-70% -$127M
IOSP icon
75
Innospec
IOSP
$2.27B
$56.8M 0.61%
828,145
+41,750
+5% +$2.9M

Similar funds

Champlain Investment Partners's Q1 2018 Portfolio in Review

As of Q1 2018, Champlain Investment Partners held 128 positions worth $9.25B, up 4.7% from $8.84B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Champlain Investment Partners's Q1 2018 filing shows 12 new, 58 increased, 52 reduced and 5 closed positions. Its largest new stake was Gates Industrial Corp: 4,278,620 shares worth $74.9M. The largest sale was Snyders-Lance, Inc., an estimated $233M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 22% a quarter earlier, followed by Technology and Industrials.

  • Champlain Investment Partners's largest Q1 2018 buy was Gates Industrial Corp: 4,278,620 shares worth $74.9M.
  • Champlain Investment Partners added most to Sensient Technologies in Q1 2018, an estimated $47M increase.
  • Champlain Investment Partners's biggest Q1 2018 reduction was WEX, cutting an estimated $127M.
  • Champlain Investment Partners fully exited Snyders-Lance, Inc. in Q1 2018, selling an estimated $233M.
  • Champlain Investment Partners's ten largest holdings make up 20% of its $9.25B portfolio in Q1 2018.
  • Champlain Investment Partners opened 12 new positions and closed 5 in Q1 2018.
  • Champlain Investment Partners's portfolio value rose 4.7% quarter-over-quarter to $9.25B.

Based on Champlain Investment Partners's 13F filing for Q1 2018, filed 14 May 2018.